Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,087.38 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Jan 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

The Trillion-Dollar Heavyweight: Eli Lilly Surge Signals Unrivaled Dominance in the GLP-1 Era

January 22, 2026

Eli Lilly (NYSE: LLY) has once again demonstrated its resilience and market-leading strength, logging a significant 5.2% gain over the last five trading days as of January 22, 2026. This recent rally...

Via MarketMinute

Topics Economy

The Great Broadening: Why Early 2026 is Redefining the Market’s Winning Ticket

January 22, 2026

As the first month of 2026 draws to a close, the narrative that dominated Wall Street for the better part of three years—the undisputed reign of mega-cap technology—is rapidly fracturing. In its place,...

Via MarketMinute

Topics Economy

As Jensen Huang Preps to Visit China, How Should You Play Nvidia Stock?

January 22, 2026

Nvidia is a tech stock that has outpaced the broader markets by a significant margin over the past decade. Is NVDA still a good buy as Jensen Huang prepares to visit China?

Via Barchart.com

Topics Artificial Intelligence Government Supply Chain

The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market

January 22, 2026

The U.S. biotech sector has officially entered a new golden age. As of January 22, 2026, the industry is witnessing a "renaissance" that has effectively erased the memories of the grueling three-year...

Via MarketMinute

Topics Artificial Intelligence ETFs Initial Public Offering

Eli Lilly (LLY) Q2 2025 Earnings Call Transcript ↗

January 22, 2026

Eli Lilly (LLY) Q2 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Eli Lilly (LLY) Q3 2024 Earnings Call Transcript ↗

January 22, 2026

Eli Lilly (LLY) Q3 2024 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Eli Lilly (LLY) Q4 2024 Earnings Call Transcript ↗

January 22, 2026

Eli Lilly (LLY) Q4 2024 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Eli Lilly and Co's Options Frenzy: What You Need to Know ↗

January 22, 2026

Via Benzinga

ELI LILLY AND COMPANY INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Eli Lilly and Company’s Directors and Officers for Breach of Fiduciary Duties – LLY

January 22, 2026

From Scott+Scott Attorneys at Law LLP

Via Business Wire

Why Eli Lilly (LLY) Stock Is Up Today

January 21, 2026

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.5% in the afternoon session after the U.S. Food and Drug Administration (FDA) granted a Breakthrough Therapy designation for its...

Via StockStory

Topics Artificial Intelligence Supply Chain

Beyond the Silicon: NVIDIA and Eli Lilly Launch $1 Billion ‘Physical AI’ Lab to Rewrite the Rules of Medicine

January 21, 2026

In a move that signals the arrival of the "Bio-Computing" era, NVIDIA (NASDAQ: NVDA) and Eli Lilly (NYSE: LLY) have officially launched a landmark $1 billion AI co-innovation lab. Announced during the...

Via TokenRing AI

Topics Artificial Intelligence Economy Intellectual Property

J&J Forecasts $100 Billion Milestone for 2026 as Trump Drug Pricing Deals Reshape the Pharma Landscape

January 21, 2026

NEW BRUNSWICK, N.J. — In a landmark display of resilience and strategic pivoting, Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2025 revenues of $24.56 billion on Wednesday, January 21, 2026,...

Via MarketMinute

Topics Earnings Economy Government

Eli Lilly Stock Report: Momentum, Earnings And Analyst Targets ↗

January 21, 2026

Eli Lilly's stock is experiencing short-term volatility due to its proximity to a 52-week high and upcoming earnings, amid strong analyst support and mixed technical indicators.

Via Talk Markets

Q3 Earnings Roundup: Zoetis (NYSE:ZTS) And The Rest Of The Branded Pharmaceuticals Segment

January 20, 2026

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how branded pharmaceuticals stocks fared in Q3, starting with...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Here's How Much You Would Have Made Owning Eli Lilly and Co Stock In The Last 5 Years ↗

January 20, 2026

Via Benzinga

What Happened to Viking Therapeutics in 2025, And Is it a Buy for 2026? ↗

January 20, 2026

Despite a challenging year, the company has a lot to look forward to in the coming years.

Via The Motley Fool

Is Oral Wegovy a Game Changer for Novo Nordisk? ↗

January 20, 2026

The past couple of years have been challenging for the company. But this could be the beginning of a new chapter.

Via The Motley Fool

AstraZeneca Signals End of an Era: Formal Move to NYSE Triggers Major Index Rebalancing

January 20, 2026

LONDON — January 20, 2026 — In a milestone moment for global capital markets, pharmaceutical giant AstraZeneca (NYSE: AZN) has officially filed its formal notice of voluntary withdrawal from the Nasdaq...

Via MarketMinute

Topics Regulatory Compliance

3 Biotech Stocks That Look Like “Sure-Fire” Winners in 2026 ↗

January 20, 2026

Via MarketBeat

Prediction: This Healthcare Stock Could Soar by 72% in 2026 ↗

January 19, 2026

And the share price appreciation could happen pretty soon.

Via The Motley Fool

Down 55%, Should You Buy the Dip on Pfizer? ↗

January 19, 2026

Pfizer's stock has started to turn higher, but it is still down massively; is now the time to jump aboard?

Via The Motley Fool

Topics Intellectual Property

Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All ↗

January 19, 2026

Via MarketBeat

Topics ETFs

Silicon Meets Science: NVIDIA and Eli Lilly Launch $1 Billion AI Lab to Engineer the Future of Medicine

January 19, 2026

In a move that signals a paradigm shift for the pharmaceutical industry, NVIDIA (NASDAQ: NVDA) and Eli Lilly and Company (NYSE: LLY) have announced the launch of a $1 billion joint AI co-innovation...

Via TokenRing AI

Topics Artificial Intelligence

The Best Healthcare Stocks to Buy With $5,000 in 2026 and Hold Forever ↗

January 19, 2026

All three of these healthcare giants are leaders in their niches.

Via The Motley Fool

Topics Artificial Intelligence

The Trillion-Dollar Pharmacopeia: Eli Lilly’s (LLY) Dominance in the Age of Incretins

January 19, 2026

As of January 19, 2026, the pharmaceutical landscape is being redefined by a single name: Eli Lilly and Company (NYSE: LLY). Once a steady, century-old stalwart known for its dominance in the insulin...

Via Finterra

Topics Economy

The New Era of Johnson & Johnson: A 2026 Deep-Dive Research Feature

January 19, 2026

As of January 19, 2026, Johnson & Johnson (NYSE: JNJ) stands as a radically different enterprise than the one most investors recognized just three years ago. Following the successful spin-off of its...

Via Finterra

Topics Artificial Intelligence Bankruptcy Economy

Prediction: 2026 Will Be the Year of Eli Lilly ↗

January 19, 2026

A catalyst lies just ahead.

Via The Motley Fool

Should Investors Worry About Regional Banks After One Firm Dumped 1.8 Million Western Alliance Shares? ↗

January 18, 2026

Western Alliance Bancorporation delivers commercial and consumer banking solutions across key western U.S. markets.

Via The Motley Fool

This Is My No. 1 Recommended Vanguard ETF to Buy in 2026 ↗

January 18, 2026

The stars could be aligning for healthcare stocks this year. This Vanguard ETF is a great way to play it.

Via The Motley Fool

Topics ETFs Economy

Could Acquiring Ventyx Biosciences Send Eli Lilly Stock Soaring in 2026? ↗

January 17, 2026

The pharmaceutical leader has plenty of cash and is using it effectively.

Via The Motley Fool

Topics Intellectual Property

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.